Overview

A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
0
Participant gender:
All
Summary
A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Cyclosporine
Cyclosporins
Tofacitinib
Criteria
Inclusion Criteria:

- Symptoms of dry eye for at least 6 months.

- Signs of moderate to severe dry eye

Exclusion Criteria:

- Women who are nursing or pregnant

- Participation in other studies within 30 days of screening visit

- Ocular disorders that may confound interpretation of study results